Correlations between Mortality-to-Incidence Ratios and Health Care Disparities in Testicular Cancer

Wen-Jung Chen, Cheng-Yu Huang, Yu-Hui Huang, Shao-Chuan Wang, Tzuo-Yi Hsieh, Sung-Lang Chen, Wen-Wei Sung and Tsung-Hsien Lee
Additional contact information
Wen-Jung Chen: Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan
Cheng-Yu Huang: Department of Urology, National Taiwan University Hospital, Taipei 10002, Taiwan
Yu-Hui Huang: Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan
Shao-Chuan Wang: Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan
Tzuo-Yi Hsieh: Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan
Sung-Lang Chen: Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan
Wen-Wei Sung: Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan
Tsung-Hsien Lee: Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan

IJERPH, 2019, vol. 17, issue 1, 1-10

Abstract: The mortality-to-incidence ratio (MIR) is associated with the clinical outcomes of different types of cancer as well as the ranking of health care systems. However, the association between MIRs for testicular cancer and health care disparities, including differences in expenditures and health system rankings, has not yet been reported. We used the Spearman’s rank correlation coefficient (CC) to analyze the correlation between testicular cancer MIRs and both total expenditures on health/gross domestic product (e/GDP) and the World Health Organization’s (WHO) health system rankings. After screening the data for quality and missing information, 57 countries were chosen for analysis. Generally, developed countries and regions had relatively high rates of incidence/mortality, but with a favorable MIR. Among the continents, Europe had the highest incidence rates, whereas the highest MIRs were in Africa. Globally, favorable testicular cancer MIRs were observed in countries with both a high e/GDP and a good WHO ranking (R 2 = 0.325, p < 0.001 and CC = −0.568, p < 0.001; R 2 = 0.367, p < 0.001 and CC = 0.655, p < 0.001, respectively). In conclusion, the MIR for testicular cancer varies in countries and regions based on both their total health expenditure and their health care system ranking.

Keywords: testicular cancer; mortality; incidence; mortality-to-incidence ratio (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2019
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.mdpi.com/1660-4601/17/1/130/pdf (application/pdf)
https://www.mdpi.com/1660-4601/17/1/130/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:17:y:2019:i:1:p:130-:d:301337

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().